Stay updated on PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC

Sign up to get notified when there's something new on the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page.
Latest website image capture
Clouds background image

Latest updates to the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision: v3.5.4 was added and Revision: v3.5.3 was removed, indicating a platform upgrade. This change does not modify the trial record content or data shown on the page.
    Difference
    0.1%
    Check dated 2026-05-14T22:59:09.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision: v3.5.3 was added to the Record History, replacing the prior Revision: v3.5.2. This reflects a minor site update to the page history.
    Difference
    0.1%
    Check dated 2026-04-30T14:26:36.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The Record History now shows a new revision (v3.5.2) and removes an older revision (v3.5.0) from the version list.
    Difference
    0.1%
    Check dated 2026-04-16T10:30:58.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    New revision entry v3.5.0 added to the study record history. Revision v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-25T20:55:58.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Revision v3.4.3 was added to the Version History. Revision v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-11T14:36:19.000Z thumbnail image
  9. Check
    110 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed a government funding lapse notice and Revision: v3.4.1.
    Difference
    0.8%
    Check dated 2026-02-11T02:07:29.000Z thumbnail image

Stay in the know with updates to PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC

Enter your email address, and we'll notify you when there's something new on the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page.